Smith & Nephew plc Overview
Pro stress-test →Founded in Hull, UK, in 1856, Smith & Nephew generated annual sales of $5.8 billion in 2024 and operates as a diversified medical technology company. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management, serving healthcare providers globally with innovative surgical and therapeutic solutions.
Strategic Profile
Pro stress-test →The company's new RISE framework is designed to accelerate growth, expand margins and improve operational efficiency to strengthen shareholder returns. Smith & Nephew has outperformed peers, driven by strong sports medicine and wound care, despite ongoing ortho business challenges, with management executing a focused turnaround under CEO Deepak Nath.
Competitive Landscape
Pro stress-test →Smith & Nephew operates in three segments spanning orthopaedics, sports medicine and advanced wound management. Key competitors include Stryker and Zimmer Biomet in orthopaedics, DePuy Synthes (Johnson & Johnson) in trauma, Baxter and Medtronic in wound care, and Arthrex in sports medicine, with the company's competitive advantage centered on innovation-driven portfolio rationalization and margin expansion.
Industry Context
Smith & Nephew plc operates in Medical Devices & Healthcare Technology.
Key facts
Founded: 1856 · Headquarters: Hull, United Kingdom · Employees: 18,000 · Revenue: $5.8B · Market cap: $14.4B